Q-linea AB (publ) (STO:QLINEA)
Sweden · Delayed Price · Currency is SEK 28.00
-0.53 (-1.84%)
Oct 10, 2025, 5:29 PM CET
Q-linea AB Market Cap
Q-linea AB has a market cap or net worth of 183.60 million as of October 10, 2025. Its market cap has decreased by -45.53% in one year.
Market Cap
183.60M
Enterprise Value
150.09M
Revenue
7.93M
Ranking
n/a
PE Ratio
n/a
Stock Price
28.00
Market Cap Chart
Since December 7, 2018, Q-linea AB's market cap has decreased from 1.57B to 183.60M, a decrease of -88.30%. That is a compound annual growth rate of -26.91%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 9, 2025 | 183.60M | 127.75% |
| Dec 30, 2024 | 80.62M | -81.35% |
| Dec 29, 2023 | 432.30M | 40.95% |
| Dec 30, 2022 | 306.69M | -90.71% |
| Dec 30, 2021 | 3.30B | -28.12% |
| Dec 30, 2020 | 4.59B | 248.60% |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 7, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Swedish Orphan Biovitrum AB | 105.55B |
| Sectra AB | 58.76B |
| Getinge AB | 57.22B |
| Camurus AB | 41.49B |
| Medicover AB | 39.71B |
| Asker Healthcare Group AB | 33.44B |
| BioArctic AB | 26.56B |
| AddLife AB | 22.67B |